Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.

@article{Kamar2010PegylatedIF,
  title={Pegylated interferon-alpha for treating chronic hepatitis E virus infection after liver transplantation.},
  author={Nassim Kamar and Lionel P E Rostaing and Florence Abravanel and Cyril Garrouste and Laure Esposito and Isabelle Cardeau-Desangles and Jean Michel Mansuy and Janick S{\`e}lves and Jean Marie P{\'e}ron and Philippe Otal and Fabrice Muscari and Jacques Izopet},
  journal={Clinical infectious diseases : an official publication of the Infectious Diseases Society of America},
  year={2010},
  volume={50 5},
  pages={e30-3}
}
This study assessed the effect of a 3-month course of pegylated interferon-alpha-2a (Peg-IFN-alpha-2a) in 3 liver transplant patients with chronic active hepatitis E. A virological response was sustained for 6 and 5 months in 2 patients after Peg-IFN-alpha-2a therapy was completed. A relapse was observed in the third patient.